Patent · US Active

(S)-N-methylnaltrexone

US8916581B2 · kind B2 · utility

1Cited by

161References

29Claims

0Family size

Assignee

Progenics Pharmaceuticals, Inc. · US

Inventors

Thomas A. Boyd · Austin, US
Howard Wagoner · Monroe, US
Suketu Sanghvi · Kendall Park, US
Christopher Verbicky · Broadalbin, US
Stephen Andruski · Clifton Park, US

Key dates

Filing date	Jun 23, 2011
Grant date	Dec 23, 2014
Priority date	—
Expiry date	Jun 1, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.